Mycomune

Manufacturer: Ceva Biomune

Mycoplasma Bovis Bacterin

U.s. Vet. Lic. No.

368

Contents

This product contains the antigen listed above.

Mycomune Indications

This bacterin is recommended as an aid in the prevention of mastitis caused by Mycoplasma bovis.

Mycomune Dosage And Administration

Shake well before use. Using aseptic technique, a 2 mL dose is subcutaneously administered in the neck. It is recommended that animals are vaccinated 3 times at 2-4 week intervals prior to calving. The third dose should be administered at least 2 to 3 weeks prior to calving. A booster dose should be administered whenever field conditions warrant. It is recommended to vaccinate a few animals and observe for any unexpected reactions prior to vaccinating the entire herd. Administer epinephrine in the event of anaphylactic reaction.

Precaution(s)

Do not freeze. Store at 35-45°F (2-7°C). Use entire contents when first opened.

Mycomune Caution(s)

Notice: This product is conditionally licensed. Potency and efficacy studies are in progress.

Non-returnable product.

For veterinary use only.

Warning(s)

Do not vaccinate within 21 days before slaughter.

Product contains an adjuvant, and accidental injection into a human may cause a serious localized reaction. Seek medical attention immediately.

Patent pending

Presentation

10 doses (20 mL) and 50 doses (100 mL).

Nac No.

11290394